RecallRadar

FDA Drug recall D-0738-2022

Lansoprazole Delayed-Release Capsules, USP, 30 mg, 90-count bottle, Rx Only, Manufactured By: Dr. Reddy's Laboratories Limited, Bachupally…

On 2022-04-06 the FDA classified a Class II recall of Lansoprazole Delayed-Release Capsules, USP, 30 mg, 90-count bottle, Rx Only, Manufactured By: Dr. Reddy's Laboratories Limited, Bachupally… by Dr Reddy S Laboratories, citing failed Dissolution Specifications; during long term stability testing.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0738-2022
ClassificationClass II
Statusterminated
Initiated2022-03-23
Published2022-04-06
Last updated2026-09-13 11:52 UTC
CompanyDr Reddy S Laboratories
DistributionUS

Product

Lansoprazole Delayed-Release Capsules, USP, 30 mg, 90-count bottle, Rx Only, Manufactured By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090, India, NDC 55111-399-90.

Reason

Failed Dissolution Specifications; during long term stability testing.

Identifiers

ndc55111-398-30
ndc55111-398-60
ndc55111-398-90
ndc55111-398-01
ndc55111-398-05
ndc55111-398-79
ndc55111-399-30
ndc55111-399-60
ndc55111-399-90
ndc55111-399-01
ndc55111-399-05
ndc55111-399-79
code_infoLot# C2102911, Exp. 12/2023

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0738-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.